3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasm Metastasis
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
51
Carboplatin
51
pembrolizumab
46
Magnetic Resonance Spectroscopy
43
Pemetrexed
40
Cisplatin
35
durvalumab
24
Paclitaxel
24
osimertinib
20
Nivolumab
19
Gemcitabine
19
Radiosurgery
17
Docetaxel
17
atezolizumab
14
Taxes
12
Radiotherapy
12
Immunoglobulin G
12
Disulfides
12
130-nm albumin-bound paclitaxel
12
Radiation
11
Etoposide
11
Educational Status
11
Biopsy
11
Drug Therapy
10
Blood Specimen Collection
10
Platinum
9
Early Intervention, Educational
9
Cetuximab
9
Methods
8
Bevacizumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
OGX-011
×
90 days
×
Clear all
NCT01630733
2026-04-15
ENSPIRIT
Achieve Life Sciences
Phase 3
Completed
664 enrolled